Financials AS Latvijas Juras medicinas centrs

Equities

UOM

LV0000100741

Healthcare Facilities & Services

End-of-day quote BOERSE MUENCHEN 03:30:00 31/05/2024 am IST 5-day change 1st Jan Change
8.85 EUR -1.67% Intraday chart for AS Latvijas Juras medicinas centrs -1.67% -16.51%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 3.984 3.968 5.96 10.16 9.52 8.48
Enterprise Value (EV) 1 2.14 1.981 4.195 9.143 8.199 7.805
P/E ratio -49.9 x 23.7 x 21.8 x 11.5 x 15.2 x -13.6 x
Yield 2.01% - 0.94% 1.57% - -
Capitalization / Revenue 0.6 x 0.55 x 0.84 x 1.09 x 0.98 x 0.86 x
EV / Revenue 0.32 x 0.27 x 0.59 x 0.98 x 0.85 x 0.79 x
EV / EBITDA 17.6 x 5.71 x 8.23 x 7.83 x 7.78 x 16.3 x
EV / FCF 12.3 x 9.7 x 24.5 x -9.32 x 28.7 x -7.77 x
FCF Yield 8.14% 10.3% 4.08% -10.7% 3.48% -12.9%
Price to Book 0.74 x 0.72 x 1.08 x 1.6 x 1.4 x 1.37 x
Nbr of stocks (in thousands) 800 800 800 800 800 800
Reference price 2 4.980 4.960 7.450 12.70 11.90 10.60
Announcement Date 29/04/19 21/02/20 21/04/21 28/04/22 30/04/24 30/04/24
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 6.674 7.27 7.081 9.364 9.701 9.851
EBITDA 1 0.1216 0.3468 0.5094 1.168 1.054 0.4787
EBIT 1 -0.0791 0.1499 0.2746 0.8809 0.6263 -0.0726
Operating Margin -1.18% 2.06% 3.88% 9.41% 6.46% -0.74%
Earnings before Tax (EBT) 1 -0.0793 0.1678 0.2746 0.8809 0.6263 -0.6234
Net income 1 -0.0798 0.1678 0.2736 0.8803 0.6257 -0.6242
Net margin -1.2% 2.31% 3.86% 9.4% 6.45% -6.34%
EPS 2 -0.0998 0.2097 0.3419 1.100 0.7822 -0.7803
Free Cash Flow 1 0.1743 0.2042 0.1712 -0.9805 0.2855 -1.004
FCF margin 2.61% 2.81% 2.42% -10.47% 2.94% -10.19%
FCF Conversion (EBITDA) 143.27% 58.86% 33.6% - 27.08% -
FCF Conversion (Net income) - 121.69% 62.58% - 45.62% -
Dividend per Share 2 0.1000 - 0.0700 0.2000 - -
Announcement Date 29/04/19 21/02/20 21/04/21 28/04/22 30/04/24 30/04/24
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 1.84 1.99 1.77 1.02 1.32 0.67
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 0.17 0.2 0.17 -0.98 0.29 -1
ROE (net income / shareholders' equity) -1.42% 3.07% 4.97% 14.8% 9.52% -9.6%
ROA (Net income/ Total Assets) -0.71% 1.33% 2.38% 7.06% 4.58% -0.51%
Assets 1 11.25 12.66 11.5 12.47 13.67 123.2
Book Value Per Share 2 6.770 6.880 6.900 7.930 8.510 7.750
Cash Flow per Share 2 2.310 2.480 2.210 1.270 1.650 0.8400
Capex 1 0.09 0.19 0.52 1.11 0.84 2.48
Capex / Sales 1.3% 2.62% 7.27% 11.85% 8.7% 25.17%
Announcement Date 29/04/19 21/02/20 21/04/21 28/04/22 30/04/24 30/04/24
1EUR in Million2EUR
Estimates
  1. Stock Market
  2. Equities
  3. UOM Stock
  4. Financials AS Latvijas Juras medicinas centrs